✦ LIBER ✦

Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease

✍ Scribed by R. CAPRILLI; A. ANDREOLI; L. CAPURSO; G. CORRAO; G. D. ALBASIO; A. GIOIENI; G. ASSUERO LANFRANCHI; I. PALADINI; F. PALLONE; V. PONTI; G. P. RIGO; F. P. ROSSINI; G. C. STURNIOLO; F. TONELLI; D. VALPIANI; THE GRUPPO ITALIANO PER LO STUDIO DEL COLON E DEL RETTO (GISC)

Book ID: 108603240
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 641 KB
Volume: 8
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.1994.tb00158.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Coated oral 5-aminosalicylic acid versus

Coated oral 5-aminosalicylic acid versus placebo in maintaining remission of inactive Crohn's disease

✍ INTERNATIONAL MESALAZINE STUDY GROUP 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 512 KB

5-Aminosalicylic acid (mesalazine) use i

5-Aminosalicylic acid (mesalazine) use in Crohn's disease: A survey of the opinions and practice of Australian gastroenterologists

✍ Richard B. Gearry; Yousef Ajlouni; Sanjay Nandurkar; John H. Iser; Peter R. Gibs 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 2 views

## Background: The use of 5-aminosalicylate (5-ASA) drugs in Crohn's disease (CD) is controversial, with their continuing apparent widespread use despite high-level evidence indicating marginal benefit at best and international guidelines recommending limited indications. ## Methods: In order to